CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair

ABSTRACT: CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair

OTHER RELATED OMICS DATASETS IN: GSE84610

PROVIDER: PRJNA330629 | ENA |

REPOSITORIES: ENA